Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

458.50p
   
  • Change Today:
      18.50p
  • 52 Week High: 458.50
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.14m
  • Volume: 156,372
  • Market Cap: £486.64m
  • RiskGrade: 125
  • Beta: 0.02

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -30.6% -14.5%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.8 2.7
Pr/Book 8.0  
Latest F'cast
Revenue 43.8% 25.6%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OXB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 142.80 19.88 22.77p 54.0 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%
31-Dec-23 89.54 (188.53) (163.11)p n/a n/a n/a n/a 0.0%
31-Dec-24 128.80 (47.26) (41.75)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OXB Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 161.82 (23.48) (31.21)p n/a n/a n/a n/a 0.0%
31-Dec-26 208.03 2.78 (13.20)p n/a n/a n/a n/a 0.0%
31-Dec-27 244.81 19.58 5.88p 78.0 n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

OXB Company Announcements

Half Year Trading Update 28-Jul-2025 07:00 RNS
Director Declaration 02-Jul-2025 07:00 RNS
Block listing Interim Review 01-Jul-2025 07:00 RNS

OXB ShareCast News

Oxford Biomedica flags sharp rise in first-half ... 28-Jul-2025 ShareCast
Oxford Biomedica acquires last 10pc stake in US ... 23-Jun-2025 ShareCast
Oxford Biomedica reports first-half revenue growth 23-Sep-2024 ShareCast

OXB Top Newspaper Links

Need to know: Opec cuts forecast ... Tesco cuts ... 16-Aug-2008 Times
Need to know 10-May-2008 Times
DSG International may be losing its spark 12-Feb-2008 Telegraph

Latest OXB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

OXB Market Data

Currency UK Pounds
Share Price 458.50p
Change Today 18.50p
% Change 4.20 %
52 Week High 458.50
52 Week Low 232.50
Volume 156,372
Shares Issued 106.14m
Market Cap £486.64m
Beta 0.02
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.81% below the market average32.81% below the market average32.81% below the market average32.81% below the market average32.81% below the market average
20.93% above the sector average20.93% above the sector average20.93% above the sector average20.93% above the sector average20.93% above the sector average
Price Trend
30.01% above the market average30.01% above the market average30.01% above the market average30.01% above the market average30.01% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income Not Available
Growth
3.93% above the market average3.93% above the market average3.93% above the market average3.93% above the market average3.93% above the market average
16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 30-Jul-2025

Time Volume / Share Price
16:48 227 @ 458.50p
16:47 910 @ 446.33p
16:35 31,945 @ 458.50p
16:35 135 @ 458.50p
16:35 771 @ 458.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page